Are Bunnies the Secret to Curing Cancer?
Copy link
By Andrew Hirschfeld
Copy link
WHY YOU SHOULD CARE
Grant McFadden spent years studying a deadly virus in rabbits. Then, he found the same pathogen could be used to fight cancer in humans.
By Andrew Hirschfeld
May14, 2021
Virologist Grant McFadden spent two decades studying a deadly virus in rabbits that didn’t seem to affect humans.
Then he discovered it could actually treat cancers in humans. Now, the Taekwondo black belt is prepping for a fight against tumors, using a virus as his weapon.
Fears of mutations introduced by scientific tampering by humans are rampant throughout the sci-fi genre. The reality though? A bit less dramatic, says Grant McFadden, a virologist who has spent the past two decades trying to tweak virus treatments so they can defeat deadly diseases. There are no zombies in this film. Instead, there are bunnies that could hold the key to curing cancer.
Bio-Path Holdings Reports First Quarter 2021 Financial Results
Conference Call to be Held Today at 8:30 A.M. ET
HOUSTON, May 14, 2021 (GLOBE NEWSWIRE) Bio-Path Holdings, Inc., (NASDAQ:BPTH), a biotechnology company leveraging its proprietary DNAbilize
® liposomal delivery and antisense technology to develop a portfolio of targeted nucleic acid cancer drugs, today announced its financial results for the first quarter ended March 31, 2021 and provided an update on recent corporate developments.
“The start of 2021 has been marked by substantial progress across our portfolio of targeted nucleic cancer drugs which included both presented and published data in support of our DNAbilize platform,” stated Peter Nielsen, President and Chief Executive Officer of Bio-Path Holdings. “We recently announced the successful completion of the safety run-in of Stage 2 of the Phase 2 clinical study of prexigebersen for the treatment of acute myeloid leukemia (AML) in combination with frontl
Share
UNSW medical researchers have found a way to starve pancreatic cancer cells and ‘disable’ the cells that block treatment from working effectively. Their findings in mice and human lab models – which have been 10 years in the making and are about to be put to the test in a human clinical trial – are published today in
Cancer Research, a journal of the American Association for Cancer Research.
“Pancreatic cancer has seen minimal improvement in survival for the last four decades – and without immediate action, it is predicted to be the world’s second biggest cancer killer by 2025,” says senior author Associate Professor Phoebe Phillips from UNSW Medicine & Health.